These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 23741398)

  • 1. Genomic copy number variants: evidence for association with antibody response to anthrax vaccine adsorbed.
    Falola MI; Wiener HW; Wineinger NE; Cutter GR; Kimberly RP; Edberg JC; Arnett DK; Kaslow RA; Tang J; Shrestha S
    PLoS One; 2013; 8(5):e64813. PubMed ID: 23741398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A genome-wide association study of host genetic determinants of the antibody response to Anthrax Vaccine Adsorbed.
    Pajewski NM; Shrestha S; Quinn CP; Parker SD; Wiener H; Aissani B; McKinney BA; Poland GA; Edberg JC; Kimberly RP; Tang J; Kaslow RA
    Vaccine; 2012 Jul; 30(32):4778-84. PubMed ID: 22658931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of HLA-DR-DQ haplotypes in variable antibody responses to anthrax vaccine adsorbed.
    Pajewski NM; Parker SD; Poland GA; Ovsyannikova IG; Song W; Zhang K; McKinney BA; Pankratz VS; Edberg JC; Kimberly RP; Jacobson RM; Tang J; Kaslow RA
    Genes Immun; 2011 Sep; 12(6):457-65. PubMed ID: 21368772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between copy number variation losses and alcohol dependence across African American and European American ethnic groups.
    Ulloa AE; Chen J; Vergara VM; Calhoun V; Liu J
    Alcohol Clin Exp Res; 2014 May; 38(5):1266-74. PubMed ID: 24512105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anthrax Vaccine Precipitated Induces Edema Toxin-Neutralizing, Edema Factor-Specific Antibodies in Human Recipients.
    Dumas EK; Gross T; Larabee J; Pate L; Cuthbertson H; Charlton S; Hallis B; Engler RJM; Collins LC; Spooner CE; Chen H; Ballard J; James JA; Farris AD
    Clin Vaccine Immunol; 2017 Nov; 24(11):. PubMed ID: 28877928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of delayed anthrax vaccine dose on Bacillus anthracis protective antigen IgG response and lethal toxin neutralization activity.
    Pittman PR; Fisher D; Quinn X; Schmader T; Barrera-Oro JG
    Vaccine; 2013 Oct; 31(44):5009-14. PubMed ID: 24026013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of anti-protective antigen salivary IgG antibodies in recipients of the US licensed anthrax vaccine.
    Bienek DR; Chang CK; Cohen ME
    Vaccine; 2007 Aug; 25(32):5978-84. PubMed ID: 17597265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced early innate and T cell-mediated responses in subjects immunized with Anthrax Vaccine Adsorbed Plus CPG 7909 (AV7909).
    Minang JT; Inglefield JR; Harris AM; Lathey JL; Alleva DG; Sweeney DL; Hopkins RJ; Lacy MJ; Bernton EW
    Vaccine; 2014 Nov; 32(50):6847-54. PubMed ID: 24530403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Marked enhancement of the immune response to BioThrax® (Anthrax Vaccine Adsorbed) by the TLR9 agonist CPG 7909 in healthy volunteers.
    Rynkiewicz D; Rathkopf M; Sim I; Waytes AT; Hopkins RJ; Giri L; DeMuria D; Ransom J; Quinn J; Nabors GS; Nielsen CJ
    Vaccine; 2011 Aug; 29(37):6313-20. PubMed ID: 21624418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of incomplete vaccination schedules on the magnitude and duration of protective antigen-specific IgG responses in recipients of the US licensed anthrax vaccine.
    Lininger LA; Cullum ME; Lyles MB; Bienek DR
    Vaccine; 2007 Feb; 25(9):1619-25. PubMed ID: 17150286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human leukocyte antigens and cellular immune responses to anthrax vaccine adsorbed.
    Ovsyannikova IG; Pankratz VS; Vierkant RA; Pajewski NM; Quinn CP; Kaslow RA; Jacobson RM; Poland GA
    Infect Immun; 2013 Jul; 81(7):2584-91. PubMed ID: 23649091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparisons of the humoral and cellular immunity induced by live A16R attenuated spore and AVA-like anthrax vaccine in mice.
    Lv J; Zhang YY; Lu X; Zhang H; Wei L; Gao J; Hu B; Hu WW; Hu DZ; Jia N; Feng X
    Biologicals; 2017 Mar; 46():130-138. PubMed ID: 28215694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A three-dose intramuscular injection schedule of anthrax vaccine adsorbed generates sustained humoral and cellular immune responses to protective antigen and provides long-term protection against inhalation anthrax in rhesus macaques.
    Quinn CP; Sabourin CL; Niemuth NA; Li H; Semenova VA; Rudge TL; Mayfield HJ; Schiffer J; Mittler RS; Ibegbu CC; Wrammert J; Ahmed R; Brys AM; Hunt RE; Levesque D; Estep JE; Barnewall RE; Robinson DM; Plikaytis BD; Marano N;
    Clin Vaccine Immunol; 2012 Nov; 19(11):1730-45. PubMed ID: 22933399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anthrax vaccine adsorbed: further evidence supporting continuing the vaccination series rather than restarting the series when doses are delayed.
    Pittman PR; Cavicchia MA; Kingsbury JL; Johnson NA; Barrera-Oro JG; Schmader T; Korman L; Quinn X; Ranadive M
    Vaccine; 2014 Sep; 32(39):5131-9. PubMed ID: 24837771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lethal factor antibodies contribute to lethal toxin neutralization in recipients of anthrax vaccine precipitated.
    Dumas EK; Garman L; Cuthbertson H; Charlton S; Hallis B; Engler RJM; Choudhari S; Picking WD; James JA; Farris AD
    Vaccine; 2017 Jun; 35(26):3416-3422. PubMed ID: 28504191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identifying a Deletion Affecting Total Lung Capacity Among Subjects in the COPDGene Study Cohort.
    Begum F; Ruczinski I; Li S; Silverman EK; Cho MH; Lynch DA; Curran-Everett D; Crapo J; Scharpf RB; Parker MM; Hetmanski JB; Beaty TH
    Genet Epidemiol; 2016 Jan; 40(1):81-8. PubMed ID: 26643968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunological dynamics in response to two anthrax vaccines in mice.
    Lü J; He R; Dong M; Zhang L; Wang X
    Sci China C Life Sci; 2008 Oct; 51(10):872-8. PubMed ID: 18815750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive analysis and selection of anthrax vaccine adsorbed immune correlates of protection in rhesus macaques.
    Chen L; Schiffer JM; Dalton S; Sabourin CL; Niemuth NA; Plikaytis BD; Quinn CP
    Clin Vaccine Immunol; 2014 Nov; 21(11):1512-20. PubMed ID: 25185577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bridging non-human primate correlates of protection to reassess the Anthrax Vaccine Adsorbed booster schedule in humans.
    Schiffer JM; Chen L; Dalton S; Niemuth NA; Sabourin CL; Quinn CP
    Vaccine; 2015 Jul; 33(31):3709-16. PubMed ID: 26072016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of sex, race, body mass index and pre-vaccination serum progesterone levels and post-vaccination serum anti-anthrax protective immunoglobulin G on injection site adverse events following anthrax vaccine adsorbed (AVA) in the CDC AVA human clinical trial.
    Pondo T; Rose CE; Martin SW; Keitel WA; Keyserling HL; Babcock J; Parker S; Jacobson RM; Poland GA; McNeil MM
    Vaccine; 2014 Jun; 32(28):3548-54. PubMed ID: 24768633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.